KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $5,434,000 | -25.3% | 426,849 | -17.0% | 0.59% | -32.7% |
Q4 2014 | $7,279,000 | +13.9% | 514,445 | +10.7% | 0.87% | +28.9% |
Q3 2014 | $6,391,000 | -53.4% | 464,795 | -47.9% | 0.68% | -48.8% |
Q2 2014 | $13,719,000 | -8.3% | 892,011 | +1.6% | 1.32% | -12.7% |
Q1 2014 | $14,958,000 | -10.4% | 877,875 | -31.9% | 1.52% | +3.0% |
Q4 2013 | $16,701,000 | +55.8% | 1,289,711 | +21.5% | 1.47% | +17.3% |
Q3 2013 | $10,721,000 | +29.8% | 1,061,426 | -4.0% | 1.26% | +31.9% |
Q2 2013 | $8,257,000 | – | 1,105,266 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |